Hayashi M, et al. Analysis of the effect of early vs conventional nasogastric tube removal on postoperative complications after transthoracic esophagectomy: A single-center, randomized controlled trial. World Journal of Surgery (2018)
Hayashi M et al. Gastric inflammatory myofibroblastic tumortreated with combined laparoscopic and endoscopic gastric wedge resection: a case report. World Journal of Surgical Oncology (2018) 16:161 https://doi.org/10.1186/s12957-018-1460-0
Hayashi et al. Does neoadjuvant chemotherapy cancel out the negative survival impact induced by surgical complications after gastrectomy? Gastric Cancer (2019)
Hayashi et al. A low surgical Apgar score is a predictor of anastomotic leakage after transthoracic esophagectomy, but not a prognostic factor. Esophagus (2019)
Hayashi et al. Determination of the optimal surgical procedure by identifying risk factors for pneumonia after transthoracic esophagectomy. Esophagus (2019)
Hayashi et al. THUMP domain containing 2 protein possibly induces resistance to cisplatin and 5 fluorouracil in in vitro human esophageal squamous cell carcinoma cells as revealed by transposon activation mutagenesis. The journal of Gene Medicine (2019)
Hayashi et al. Predictive Value of the Surgical Apgar Score on Postoperative Complications in Advanced Gastric Cancer Patients Treated with Neoadjuvant Chemotherapy Followed by Radical Gastrectomy: A Single-center Retrospective Study. BMC surgery (2020)
Hayashi et al. Intraoperative blood loss as an independent prognostic factor for curative resection after neoadjuvant chemotherapy for gastric cancer: a single‑center retrospective cohort study. Surgery Today (2020)
Hayashi et al. Laparoscopic mediastinal approach for retrosternal gastric conduit cancer after esophagectomy. Asian Journal of Endoscopic Surgery (2020)
Hayashi et al. Prognostic value of tumor regression grade following the administration of neoadjuvant chemotherapy as treatment for gastric/gastroesophageal adenocarcinoma: A meta-analysis of 14 published studies. European Journal of Surgical Oncology (2020)
Hayashi M, Abe M, Fujita T, Matsushita H. Assessing the Prognostic Value of Extranodal Extension in Esophageal Cancer from the Pathological Staging Perspective. J Invest Surg. 2021 Jun 6:1-9. doi: 10.1080/08941939.2021.1912221. Epub ahead of print. PMID: 34096439.
Hayashi M, Fujita T, Matsushita H. Evaluating the optimal treatment strategy for early and advanced remnant gastric cancer. ANZ J Surg. 2022 Sep 19. doi: 10.1111/ans.18049. Epub ahead of print. PMID: 36117449.
Hayashi M, Fujita T, Matsushita H. Clinical Complete Response of Recurrent Gastric Cancer after a Third-Line CPT-11 Chemotherapy. Keio Journal of Medicine. Keio J Med. 2023 Jun 25;72(2):60-64. doi: 10.2302/kjm.2022-0004-CR.
Hayashi M, Makoto Abe, Fujita T, Matsushita H. Prognostic effect of categorized tumor deposits in gastric cancer: A single-center retrospective study. Surgery. 2023 Nov 6:S0039-6060(23)00709-2. doi: 10.1016/j.surg.2023.09.039. Online ahead of print.
Hayashi M, Takaki Y. Junki M et al. Prognostic Impact of Post-operative Infectious Complications in Gastric Cancer Patients Receiving Neoadjuvant Chemotherapy: Post-hoc Analysis of a Randomized Controlled Trial, JCOG0501. Journal of Gastrointestinal Cancer.
Hayashi M, Fujita T, Matsushita H. Prognostic Relevance of Recurrent Sites of Gastric Cancer Treated with Curative Resection: A single center retrospective study. Journal of Gastric Cancer.
